KORU Medical Systems (traded under the ticker KRMD) has experienced a characteristically volatile market history typical of small-cap medical device and healthcare technology enterprises. Over recent multi-year trading periods, its share price has fluctuated across a 52-week range bounded by a low of approximately $3.14 and a high of over $6.60. Market performance has historically reacted to regulatory clearances, commercial adoption metrics of its subcutaneous infusion systems, quarterly revenue updates, and broader shifts in small-cap healthcare investor sentiment on the Nasdaq exchange.